Search results

Page results

• Brain cancer patient doing well after world-first immunotherapy treatment

  UCLH has treated the first brain cancer patient with immunotherapy prior to standard treatment as part of a pioneering trial.

• Endoscopic ultrasound (EUS) guided pancreatic collection or pseudocyst drainage

  This page aims to give you information about a way doctors can treat patients who have pancreatic collections or pseudocysts related to pancreatitis (inflammation of the pancreas).

• Research into restoring loss of smell and taste in COVID patients

  Specialist teams at UCLH and UCL are at the forefront of research which could bring hope to people who have been robbed of their sense of smell and taste after suffering the long-term legacy of COVID-19.

• One year at the Royal National ENT and Eastman Dental Hospitals

  The hospital marked the start of the year a visit by HM The Queen in February 2020. A few weeks after this celebration, the pandemic took hold and the hospital stepped up to help.

• UCLH and Whittington Health make case for closer collaboration

  UCLH and Whittington Health have a long history of working together to benefit patients, staff and our communities across Camden, Haringey, Islington and beyond. This includes services such as the virtual ward, orthopaedic surgery and paediatric dentistry.

• Gastroscopy – a guide for patients (Prolonged diet)

  This page explains what a gastroscopy is and what it involves for patients on a prolonged diet.

• UCLH coordinates cancer care for north and east London patients during the COVID-19 pandemic

  UCLH is managing one of the three cancer hubs across London, so that during the COVID-19 coronavirus pandemic cancer surgery is available for patients with the most immediate needs.

• Managing cancer treatment side effects videos

  This series of wellbeing videos have been designed to help people manage the side effects of cancer treatment.

• Biatain® dressings for radiotherapy and proton beam therapy skin reactions

  Patient information who have been recommended to use a Biatain® dressing on your skin that has broken down due to your radiotherapy or proton beam therapy treatment.

• Immunomodulatory drug for COVID-19 trialled at UCLH

  UCLH is contributing to a national priority trial of the drug ruxolitinib in patients with Covid-19 pneumonia (infection of the lungs).